Studying blood vessel damage in type 2 diabetes
Part of Hormones & metabolism clinical trials.
This early study looks at how “autophagy” (your body’s cell recycling process) relates to small blood-vessel problems in people with type 2 diabetes. It may help researchers understand mechanisms and possible future treatments, mainly for people who meet specific health and medication criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 to 80
- You have type 2 diabetes (or you can join as a healthy control if you have 1 or fewer cardiovascular risk factors)
- Your blood pressure is not uncontrolled
- You do not currently smoke, and you haven’t smoked in the last 6 months
- Your BMI is 35 or less (BMI is a weight-for-height measure)
- You do not have certain heart, kidney, eye, or active cancer/COVID conditions, and you meet key medication and allergy limits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how type 2 diabetes affects blood flow in the brain and thinking ability. It compares people with diabetes to those without, and may help understand how to protect brain health.
This study looks at people who may be on the way to developing type 2 diabetes or who have it, to see how to help and better understand the condition. Depending on the part of the study you join, it may include brain scans and sleep testing.
This study looks at how type 2 diabetes affects the way blood vessels respond during exercise. It compares people with type 2 diabetes to healthy volunteers to understand possible heart risks.
This study looks at how well the cells lining your blood vessels work and how the body's regenerative cells may behave in people with or without type 2 diabetes. It involves giving a blood sample and answering questions to help researchers understand blood vessel health.
This study looks at how newly diagnosed type 2 diabetes affects heart and blood vessel health. Researchers will follow patients over time to understand the relationship between diabetes and cardiovascular risk.
This early study looks at how a new approach may affect energy-making (mitochondria) and blood-vessel signaling in people with insulin-dependent type 1 diabetes. It may help researchers understand whether these pathways can be improved in type 1 diabetes.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.